Purpose: The percentage of individuals who were fully vaccinated against COVID-19 was 53% worldwide, 62% in Asia, and 11% in Africa at the time of writing (February 9, 2022). In addition to administrative issues, vaccine hesitancy is an important factor contributing to the relatively low rate of vaccination. The Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S) was developed to assess COVID-19 vaccination acceptance levels. However, it has only been tested among Taiwanese, mainland Chinese, and Ghanaian populations (Chen et al, 2021; Fan et al, 2021; Yeh et al, 2021). Therefore, the present study examined the construct validity and measurement invariance of the MoVac-COVID19S among individuals from five countries (ie, Taiwan,...
The Covid-19 pandemic is expected to continue to impose enormous burdens of morbidity and mortality ...
International audienceDespite unprecedented progress in developing COVID-19 vaccines, global vaccina...
BACKGROUND: Multiple COVID-19 vaccines have now been licensed for human use, with other candidate va...
Background: As the number of COVID-19 cases grows worldwide, one solution to the global pandemic is ...
Vaccination is fast becoming a key intervention against the ongoing COVID-19 pandemic. We conducted ...
Summary Background As vaccination campaigns are deployed worldwide, addressing vaccine hesitancy is ...
The delay or refusal of vaccination, which defines vaccine hesitancy, is a major challenge to succes...
Abstract Background The availability of various types of COVID-19 vaccines and diverse characteristi...
COVID-19 vaccine acceptance rates in countries from Asia and the Pacific, adapted from the review st...
International audienceOBJECTIVE: Describe demographical, social and psychological correlates of will...
Objectives This study is aimed to investigate the COVID-19 vaccine acceptancy among public, along wi...
Background Mass vaccination campaigns have significantly reduced the COVID-19 burden. However, vacci...
The aim of this study was to investigate the COVID-19 vaccination acceptance rate and its determinan...
Background: mass vaccination campaigns have significantly reduced the COVID-19 burden. However, vacc...
Despite the availability of effective and safe vaccines, the acceptance of COVID-19 vaccination is s...
The Covid-19 pandemic is expected to continue to impose enormous burdens of morbidity and mortality ...
International audienceDespite unprecedented progress in developing COVID-19 vaccines, global vaccina...
BACKGROUND: Multiple COVID-19 vaccines have now been licensed for human use, with other candidate va...
Background: As the number of COVID-19 cases grows worldwide, one solution to the global pandemic is ...
Vaccination is fast becoming a key intervention against the ongoing COVID-19 pandemic. We conducted ...
Summary Background As vaccination campaigns are deployed worldwide, addressing vaccine hesitancy is ...
The delay or refusal of vaccination, which defines vaccine hesitancy, is a major challenge to succes...
Abstract Background The availability of various types of COVID-19 vaccines and diverse characteristi...
COVID-19 vaccine acceptance rates in countries from Asia and the Pacific, adapted from the review st...
International audienceOBJECTIVE: Describe demographical, social and psychological correlates of will...
Objectives This study is aimed to investigate the COVID-19 vaccine acceptancy among public, along wi...
Background Mass vaccination campaigns have significantly reduced the COVID-19 burden. However, vacci...
The aim of this study was to investigate the COVID-19 vaccination acceptance rate and its determinan...
Background: mass vaccination campaigns have significantly reduced the COVID-19 burden. However, vacc...
Despite the availability of effective and safe vaccines, the acceptance of COVID-19 vaccination is s...
The Covid-19 pandemic is expected to continue to impose enormous burdens of morbidity and mortality ...
International audienceDespite unprecedented progress in developing COVID-19 vaccines, global vaccina...
BACKGROUND: Multiple COVID-19 vaccines have now been licensed for human use, with other candidate va...